3IPB

human transthyretin (ttr) complexed with a palindromic bivalent amyloid inhibitor (11 carbon linker).

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 92
  • Norm. En. per Res.: -4.45
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-104.6068	-0.6964	-304.094	-409.3972	92	15	6	10973	0	31	31

Interface residues

• A-B: ALA108A, ALA108B, ALA109A, ALA109B, ALA120A, ALA120B, ALA91A, ALA91B, ALA97A, ALA97B, ARG103A, ARG103B, ARG104A, ARG104B, ASN98A, ASN98B, ASP99A, GLU72A, GLU72B, GLU89A, GLU89B, GLU92A, GLU92B, GLY67A, GLY67B, HIS88A, HIS88B, HIS90A, HIS90B, ILE107A, ILE107B, ILE68A, ILE68B, LEU110A, LEU110B, LEU12A, LEU12B, LYS35A, LYS35B, LYS70A, LYS70B, LYS76A, LYS76B, PHE64A, PHE64B, PHE87A, PHE87B, PHE95A, PHE95B, PRO113A, PRO113B, PRO86A, PRO86B, SER100A, SER112A, SER112B, SER115A, SER115B, SER117A, SER117B, SER85A, SER85B, THR106A, THR106B, THR118A, THR118B, THR119A, THR119B, THR75A, THR75B, THR96A, THR96B, TRP41A, TRP41B, TYR105A, TYR105B, TYR114A, TYR114B, TYR116A, TYR116B, TYR69A, TYR69B, VAL121A, VAL121B, VAL122A, VAL122B, VAL71A, VAL71B, VAL93A, VAL93B, VAL94A, VAL94B